MARKET

GUTS

GUTS

Fractyl Health
NASDAQ
0.7430
-0.0559
-7.00%
After Hours: 0.7500 +0.007 +0.94% 19:33 06/26 EDT
OPEN
0.7800
PREV CLOSE
0.7989
HIGH
0.8150
LOW
0.7430
VOLUME
1.53M
TURNOVER
--
52 WEEK HIGH
2.445
52 WEEK LOW
0.3772
MARKET CAP
117.88M
P/E (TTM)
-0.4866
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at GUTS last week (0615-0619)?
Weekly Report · 6d ago
Insider Makes Bold Move With Fresh Buy Into Fractyl Health Stock
TipRanks · 06/16 02:06
Weekly Report: what happened at GUTS last week (0608-0612)?
Weekly Report · 06/15 09:19
Fractyl Health Directors Quietly Make Bold Moves With Fresh Stock Buys
TipRanks · 06/12 02:05
Fractyl Health Stockholders Back Board and Auditor at Meeting
TipRanks · 06/11 23:03
Fractyl Health shareholders elected Class II directors at annual meeting
PUBT · 06/11 21:16
Fractyl Health director William Bradley acquires 68,493 common shares for $50,333.52
PUBT · 06/11 21:05
Fractyl Health director Ian Sheffield acquires 35,000 common shares worth $25,529
PUBT · 06/11 21:01
More
About GUTS
Fractyl Health, Inc. is a metabolic therapeutics company. The Company is focused on developing new approaches to the treatment of metabolic diseases, including obesity and type 2 diabetes (T2D). The Company’s lead product candidate, Revita, is designed to remodel the duodenal lining via hydrothermal ablation (i.e. duodenal mucosal resurfacing) to reverse damage to intestinal nutrient sensing and signaling mechanisms caused by chronic high-fat and high-sugar diets that are a root cause of metabolic disease. The Revita clinical program is focused on patients living with obesity who want to maintain their weight loss after GLP-1 drug discontinuation. The Company’s Rejuva platform focuses on developing adeno-associated virus (AAV)-based, locally delivered gene therapies for the treatment of obesity and T2D. The Rejuva platform leverages advanced delivery systems and proprietary screening methods to identify and develop metabolically active gene therapy candidates targeting the pancreas.

Webull offers Fractyl Health Inc stock information, including NASDAQ: GUTS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GUTS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GUTS stock methods without spending real money on the virtual paper trading platform.